| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Gastroenterology Unit, Department of Pediatrics (S.A.Z., D.C.B.); Division of Bone Diseases, Department of Internal Medicine (R.R., J.-P.B.); and Division of Nuclear Medicine, Department of Radiology (D.O.S.), University Hospital, 1211 Geneva 14, Switzerland
Address all correspondence and requests for reprints to: Dr. S. A. Zamora, Division of Bone Diseases, Department of Internal Medicine, University Hospital, 1211 Geneva 14, Switzerland. E-mail: samuel.zamora{at}hcuge.ch
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The present study aimed at determining whether vitamin D supplementation during the first year of life in breast-fed infants was associated with greater aBMD/BMC in later childhood at specific skeletal sites.
| Subjects and Methods |
|---|
|
|
|---|
The protocol was approved by the ethics committee of the Department of Pediatrics of the University Hospital of Geneva. A retrospective cohort study was performed on 149 healthy prepubertal Caucasian girls who were enrolled in a randomized trial of calcium supplementation (9). These girls were recruited through the Public Health Youth Service. They were free of chronic disease, gastrointestinal disease capable of inducing malabsorption, and congenital or acquired bone disease and did not use regular medication. At enrolment and before calcium supplementation, they had anthropometric measurements, calcium intake assessment by a frequency questionnaire, and measurement of bone variables as previously described (9). Subsequently, the following information was obtained from birth records and from a questionnaire sent to participating families and their pediatricians: gestational age, weight and height at birth and at 1 yr of age, type of feeding during the first 6 months of life, and vitamin D supplementation. Information was obtained for 127 girls (85% response rate). From this group were excluded subjects who were exclusively formula fed during the first 6 months of life (n = 7), those born before 37 weeks gestation (n = 5), those who avoided milk products in infancy for query milk allergy (n = 3), and those for whom vitamin D supplementation could not be reliably specified (n = 6). Finally, 106 girls constituted the study population and were divided into supplemented (n = 91) and unsupplemented groups (n = 15).
Measurement of bone variables
BMC (grams), bone area (BA; square centimeters), and aBMD (g/cm2) were determined by dual energy x-ray absorptiometry (DXA) using a Hologic, Inc., QDR-2000 instrument (Waltham, MA). The coefficient of variation for repeated measurements of various skeletal sites varied between 1.01.6% for aBMD and 0.33% for BMC. An estimate of volumetric mineral density [bone mineral apparent density (BMAD)] was calculated as previously described for lumbar spine, midradius, femoral diaphysis, and femoral neck (11, 12). Six skeletal sites were assessed as previously described (9): distal metaphysis of the radius, distal diaphysis of the radius, femoral neck, femoral trochanter, femoral middiaphysis, and L2L4 vertebrae in antero-posterior view.
Vitamin D receptor (VDR) gene polymorphisms
DNA was extracted from saliva, and VDR gene allelic polymorphisms were determined by BsmI endonuclease restriction after specific PCR amplification (10). Genotypic polymorphism was defined as BB (absence of restriction site on both alleles), bb (presence of restriction site on both alleles), or Bb (heterozygous).
Statistical analysis
The results are the mean ± SEM. Demographic and anthropometric characteristics and bone variables were compared between the supplemented and unsupplemented groups using a two-tailed Students t test when variables were normally distributed and a Mann-Whitney U test otherwise. The Fisher exact test was used for comparison of frequencies. The possible confounding effect of VDR genotype, age, weight, and height on the relationships between vitamin D supplementation and BMC, aBMD, and BMAD (dependent variables) was taken into account using multiple linear regression. P < 0.05 was considered significant.
| Results |
|---|
|
|
|---|
The demographic and anthropometric characteristics and calcium
intake were similar between the supplemented and unsupplemented groups
(Table 1
). The supplemented group had
received 400 IU/day vitamin D (cholecalciferol) for a median
supplementation period of 12 months (range, 248 months). In the
unsupplemented group reasons for nonsupplementation were lack of
prescription (n = 7), poor palatability of the vitamin D
supplement (n = 5), and parental choice (n = 3). The median
duration of breast feeding was similar in the supplemented (4 months)
and unsupplemented (5.5 months) groups. There was no association
between duration of breast feeding and BMC or BMD.
|
BMC was significantly higher in the supplemented group at the
level of femoral neck and femoral trochanter. At the levels of the
radius, femoral diaphysis, and lumbar spine, the difference was of
lower magnitude (39%) and not statistically significant. BA at the
different skeletal sites tended to be higher in the supplemented group,
but did not reach statistical significance (Table 2
). aBMD was significantly higher in the
supplemented group at the level of the radial metaphysis (0.301 ±
0.003 vs. 0.283 ± 0.008; P = 0.03),
femoral neck (0.638 ± 0.007 vs. 0.584 ± 0.021;
P = 0.007), and femoral trochanter (0.508 ± 0.006
vs. 0.474 ± 0.016; P = 0.04; Fig. 1
). aBMD was not statistically different
at the levels of lumbar spine (0.626 ± 0.006 vs.
0.598 ± 0.019; P = 0.1), radial diaphysis
(0.434 ± 0.003 vs. 0.427 ± 0.010;
P = 0.1), and femoral diaphysis (1.030 ± 0.009
vs. 0.996 ± 0.026; P = 0.2). BMAD,
taken as an estimate of volumetric density, was higher in the
supplemented group at the level of the femoral neck only (Table 2
). In
multiple regression models adjusting for the effects of age, weight,
and height at DXA, the differences in BMC, aBMD, and BMAD described
above remained significant in the supplemented group.
|
|
As VDR gene polymorphisms have been associated with aBMD levels in prepubertal girls (10, 13), it appeared important to study the polymorphisms distribution in our population. The distribution of the VDR gene polymorphisms was slightly different in the two groups. The VDR Bb genotype was significantly more frequent in the supplemented group (47 of 86 vs. 3 of 15; P = 0.02). The prevalences of BB (8 of 86 vs. 4 of 15) and bb alleles (31 of 86 vs. 8 of 15) were not statistically different. When VDR genotype was taken into account by multiple linear regression, aBMD at the level of the femoral neck remained significantly higher in the supplemented group. After adjusting for the effects of age, weight, height at time of DXA, and VDR genotype, femoral neck aBMD remained higher by 0.045 g/cm2 in the supplemented group (P = 0.02).
| Discussion |
|---|
|
|
|---|
Our population was homogeneous, and the supplemented and unsupplemented groups were similar in terms of calcium intake and demographic characteristics, such as race, age, and anthropometric parameters. Measurements of bone variables were made with the same instrument using a standardized protocol, and observers were unaware of the vitamin D supplementation history of participants.
Our findings are in agreement with previous studies comparing supplemented and unsupplemented healthy term breast-fed infants (4, 6, 8). These studies measured BMC at the junction of the middle and distal radius using single photon absorptiometry after a relatively short follow-up period (16 weeks to 12 months) and failed to show an increase in BMC at the distal radius level. In our study, the difference in BMC of 3% at the radial diaphysis was not statistically significant. Skeletal sites differ in structure (cortical or trabecular bone) and react differently to environmental and nutritional factors (9, 10). For instance, calcium supplementation in prepubertal girls appeared to increase bone mass accrual preferentially in the appendicular skeleton (9). In the present study BMC was significantly higher at the levels of femoral neck and trochanter in the vitamin D-supplemented group. In a way analogous to the sensitivity to calcium supplements, vitamin D supplementation may have a different impact on specific skeletal sites. Our findings might be particularly clinically relevant considering the risk of fracture at the femoral neck level in later life.
Several limitations to our study need to be stressed. An association between vitamin D supplementation and increased bone mineral mass does not imply causality. The population studied was homogenous, and no difference was found in the demographic characteristics. However several potential confounding factors, such as calcium consumption and sunlight exposure in infancy, were impossible to appraise and may contribute to the observed difference between the two groups. The information on vitamin D was evaluated several years after the supplementation, and misclassification of this variable may have occurred. The VDR BB polymorphism has been associated with lower BMD in prepubertal girls (10, 13), and this genotype tended to be more prevalent in the unsupplemented group. However, the small number of subjects precluded any reliable relationship being established. Furthermore, adjusting for VDR genotype in a multiple regression model did not attenuate the difference in femoral neck aBMD; the latter remained significantly higher in the supplemented group.
In conclusion, vitamin D supplementation in infancy could be associated with increased BMC and aBMD at specific skeletal sites in 8-yr-old prepubertal girls. If this positive influence was maintained later in life, primary prevention in the pediatric population would need serious consideration. Thus, a possible beneficial effect of early vitamin D supplementation on bone mineral mass and density at specific skeletal sites deserves further investigation in prospective controlled studies.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received March 18, 1999.
Revised June 15, 1999.
Accepted July 9, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. N. Taylor, C. L. Wagner, and B. W. Hollis Vitamin D Supplementation during Lactation to Support Infant and Mother J. Am. Coll. Nutr., December 1, 2008; 27(6): 690 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Gordon, H. A. Feldman, L. Sinclair, A. L. Williams, P. K. Kleinman, J. Perez-Rossello, and J. E. Cox Prevalence of Vitamin D Deficiency Among Healthy Infants and Toddlers Arch Pediatr Adolesc Med, June 1, 2008; 162(6): 505 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lilleby Review: Bone status in juvenile systemic lupus erythematosus Lupus, August 1, 2007; 16(8): 580 - 586. [Abstract] [PDF] |
||||
![]() |
J. H. D. Bassett, P. J. O'Shea, S. Sriskantharajah, B. Rabier, A. Boyde, P. G. T. Howell, R. E. Weiss, J.-P. Roux, L. Malaval, P. Clement-Lacroix, et al. Thyroid Hormone Excess Rather Than Thyrotropin Deficiency Induces Osteoporosis in Hyperthyroidism Mol. Endocrinol., May 1, 2007; 21(5): 1095 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Ziegler, B. W. Hollis, S. E. Nelson, and J. M. Jeter Vitamin D Deficiency in Breastfed Infants in Iowa Pediatrics, August 1, 2006; 118(2): 603 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
J H Davies, B A J Evans, and J W Gregory Bone mass acquisition in healthy children Arch. Dis. Child., April 1, 2005; 90(4): 373 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Bonjour Is Peripuberty the Most Opportune Time to Increase Calcium Intake in Healthy Girls? IBMS BoneKEy, March 1, 2005; 2(3): 6 - 11. [Full Text] [PDF] |
||||
![]() |
M. Heer, C. Mika, I. Grzella, N. Heussen, and B. Herpertz-Dahlmann Bone turnover during inpatient nutritional therapy and outpatient follow-up in patients with anorexia nervosa compared with that in healthy control subjects Am. J. Clinical Nutrition, September 1, 2004; 80(3): 774 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Specker Nutrition Influences Bone Development from Infancy through Toddler Years J. Nutr., March 1, 2004; 134(3): 691S - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Abrams and S. A. Atkinson Calcium, Magnesium, Phosphorus and Vitamin D Fortification of Complementary Foods J. Nutr., September 1, 2003; 133(9): 2994S - 2999. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |